Gardasil Gains Blockbuster Status In Its First Year On The Market
Merck’s HPV vaccine generated $1.1 billion in sales year-to-date, firm reports during third quarter earnings call.
Merck’s HPV vaccine generated $1.1 billion in sales year-to-date, firm reports during third quarter earnings call.